期刊文献+

肿瘤坏死因子相关凋亡诱导配体的克隆、表达及重新折叠 被引量:5

The cloning, expression and refolding of TNF-related apoptosis inducing ligand
下载PDF
导出
摘要 目的 :人的肿瘤坏死因子相关凋亡诱导配体 (TNF relatedapoptosisinducingligand ,TRAIL)基因经扩增后 ,克隆在大肠杆菌中表达并重新折叠并获得有活性的TRAIL蛋白。方法 :用PCR的方法从人胎盘cDNA文库中扩增TRAIL基因 ,经序列分析鉴定 ,再克隆到原核表达载体 pET11a ,经E .coliBL2 1(DE3)表达 ,电泳鉴定后 ,柱层析纯化 ,重新折叠 ,流式细胞术等方法检测其促凋亡活性。结果 :得到了TRAIL基因 ,并构建了可在大肠杆菌中表达的载体 pET11 TRAIL1(含TRAILcDNA序列 418 933)及可在真核细胞中表达的载体pLNCX TRAIL2 (含TRAILcDNA序列 88 933)。取前者在E .coliBL2 1(DE3)中表达 ,经纯化 ,重新折叠得到了复性的TRAIL蛋白。检测其对人白血病细胞株Jurkat有诱导凋亡的作用。结论 :从人胎盘cDNA文库中扩增TRAIL基因 ,在大肠杆菌中表达、重新折叠、纯化后 。 Objective: To clone human TRAIL(TNF related apoptosis inducing ligand) gene into E.coli expression vector to get active TRAIL protein after refolding and purification. Methods: The human TRAIL gene was amplified from the human placenta cDNA library, and cloned into prokaryotic expression vector pET11a after being sequenced. The plasmid was transformed into E.coli BL21 (DE3), followed by expression, refolding and purification. The protein activity was measured by flow cytometry. Results: The TRAIL 1 from 418 933 of the cDNA (the coding region of TRAIL was 111 281) and TRAIL 2 from 88 933 of the cDNA (coding for full length TRAIL) were obtained. The prokaryotic and eukaryotic expression vectors were pET11 TRAIL1 and pLNCX TRAIL2 respectively. The former was transformed and expressed in E.coli BL21 (DE3), then the refolded and purified protein was obtained. The apoptosis of human leukemia cell line Jurkat had been successfully induced by this TRAIL protein. Conclusion: The human TRAIL gene was amplified from the human placenta cDNA library, and after expression in E.coli , refolding and purification, the active TRAIL protein was obtained.
出处 《北京医科大学学报》 CSCD 2000年第5期387-390,共4页 Journal of Peking University(Health Sciences)
基金 国家自然科学基金!(39870 85 0 )
关键词 基因表达 肿瘤 基因治疗 肿瘤坏死因子 TRAIL Gene expression Protein folding Cloning, molecular TRAIL Tumor necrosis factor/metab
  • 相关文献

参考文献5

  • 1魏晓超 王新娟 等.四环素调控TRAIL表达系统在人胃瘤细胞中的建立及作用[J].中国学术期进文摘(科学快报),2000,6(10):1282-1284.
  • 2Wang X,J Mol Biol,2000年,295卷,4期,903页
  • 3魏晓超,中国学术期刊文摘,2000年,6卷,10期,1282页
  • 4Wang X,Science,1998年,281期,1662页
  • 5Lin X L,J Bio Chem,1992年,267期,17257页

同被引文献33

  • 1付泳航,李茹冰,佟明华,李继东,杨联萍,孔祥平.重组pichia pastoris高密度发酵表达肿瘤坏死因子相关凋亡诱导配体的研究[J].实用临床医学(湖北),2004,18(3):1-3. 被引量:1
  • 2李招发,于学玲,黄金路,方宏清,陈惠鹏.重组巴曲酶在毕赤酵母中的高效表达[J].生物工程学报,2007,23(3):483-486. 被引量:8
  • 3周俊宜 罗超权.RT-PCR法检测恶性肿瘤细胞端粒酶RNA组分的研究[J].中国肿瘤生物治疗杂志,2000,7(3):202-202.
  • 4Wiley S R, Sehooley K, Smolak P J, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity, 1995,3 : 673-682.
  • 5Ashkenazi A, Pai R C, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo21 ligand[ J]. J Clin Invest, 1999,104 : 155-162.
  • 6Walczak H, Miller R E, Ariail K, et al. Tumoficidal activity of tumor necrosis factor-related apoptosisinducing ligand in vivo [ J ]. Nat Med, 1999,5:157-163.
  • 7Kagawa S, He C, Gu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene[ J]. Cancer Res, 2001,61 : 3330-3338.
  • 8Frank S, Kohler U, Schackert G, et al. Expression of TRAIL and its receptors in human brain tumors [ J]. Biochem Biophys Res Commun, 1999,257 : 454-459.
  • 9Harald W, Dieter M,Thomas W,et al. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative [ J]. Oncogene, 2001,20:4101-4106.
  • 10Jong S, Timmer T, Heijenbrok F J, et al. Death receptor ligands, in particular TRAIL, to overcome drug resistance[ J]. Cancer Metastasis Rev, 2001,20:51-56.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部